摘要
细菌中抗生素耐药性的迅速发展威胁着将人类带回到"后抗生素时代"。新德里金属β-内酰胺酶(NDM-1)几乎可以水解所有的β-内酰胺抗生素,包括碳青霉烯。携带blaNDM-1基因的细菌被称为超级细菌,至今临床上仍缺乏针对NDM-1的抑制剂。新型NDM-1抑制剂的研发是一个具有挑战性但值得深入研究的领域。本文对NDM-1及其抑制剂研究进展进行阐述,为后续研发提供借鉴。
The rapid development of antibiotic resistance among bacterial pathogens has threatened to take humans back to the"pre-antibiotic era".The New Delhi metallo-β-lactamase(NDM-1)hydrolyzes nearly allβ-lactam antibiotics including carbapenems.Bacterial strains carrying blaNDM-1 gene are termed"superbugs"and clinical inhibitors of NDM-1 have not yet been identified.Discovery of novel NDM-1 inhibitors is a challenging but rewarding research area.This review focuses on the structural characteristics and catalytic mechanisms of NDM-1,and comprehensively summarizes the development of NDM-1 inhibitors in order to facilitate the further development of NDM-1 inhibitors.
作者
金文彬
李江
李娇
陈凌云
侯安国
马云淑
JIN Wen-bin;LI Jiang;LI Jiao;CHEN Ling-yun;HOU An-guo;MA Yun-shu(Yunnan University of Chinese Medicine,Kunming 650500,China;Key Laboratory of Applied Drug Delivery System and Preparation Technology,Kunming 650500,China)
出处
《药学学报》
CAS
CSCD
北大核心
2020年第6期1157-1165,共9页
Acta Pharmaceutica Sinica
基金
国家自然科学基金资助项目(81673682)
云南省科技厅中医联合专项重点项目(2018FF001-008)
云南省教育厅科学研究基金资助项目(2019J1057)。